First Preliminary Results of a New Hybrid Approach to Treat Persistent Atrial Fibrillation: The Convergent Procedure Together with Left Atrial Appendage Electrical Isolation/Closure

2021 ◽  
Author(s):  
M. Schermer ◽  
S. Tsvelodub ◽  
V. Vulevic ◽  
M. Laß ◽  
T. Hanke
2018 ◽  
Vol 42 (3) ◽  
pp. 306-308
Author(s):  
Antonio Madaffari ◽  
Anett Große ◽  
Elisabetta Conci ◽  
J. Christoph Geller

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Shaohui Wu ◽  
Guangchen Zou ◽  
Xu Liu ◽  
Weifeng Jiang ◽  
Mu Qin ◽  
...  

Extrapulmonary vein focal sources have been recognized as the source of atrial fibrillation in some cases, and empiric electric isolation of the left atrial appendage has been proposed for long-standing persistent atrial fibrillation by some. Here, we present a case of redo ablation of long-standing persistent atrial fibrillation in which the left atrial appendage played a key role in maintaining AF during ablation, and atrial fibrillation was terminated by electrical isolation of the LAA. During the ablation, a rare phenomenon of half of the atria in atrial fibrillation while the other half of the atria in atrial flutter was seen.


Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
David C Kress ◽  
Lynn Erickson ◽  
Ana C Perez Moreno ◽  
Imran Niazi ◽  
M. Eyman Mortada ◽  
...  

Introduction: The hybrid, or convergent procedure, uses a minimally invasive combined epicardial/endocardial ablation approach for patients in persistent AF. In the staged hybrid approach, the electrophysiologist performs the endocardial ablation a minimum of 30 days after the surgeon performs epicardial ablation. Placement of a left atrial appendage (LAA) closure device (AtriCure AtriClip) has been shown to electrically isolate the LAA. Added to the scar formation on the posterior wall via epicardial ablation, it eliminates additional substrate in persistent atrial fibrillation (AF). Hypothesis: Patients with persistent AF who underwent a staged hybrid approach with thoracoscopic placement of the AtriClip may have less likelihood of arrhythmia recurrence between 3 and 12 months compared with those who underwent nonstaged hybrid ablations without use of the AtriClip. Methods: Patients in persistent or long-standing paroxysmal AF underwent ablation using either a staged hybrid approach with AtriClip (n=23) or a nonstaged hybrid approach without AtriClip (n=136). Groups were compared by running a t-test (mean±SD) or Wilcoxon rank sum [median, interquartile range (IQR)]. Categorical data were compared with Pearson’s chi-squared test. Results: Significantly fewer patients who had undergone a staged hybrid with AtriClip recurred with arrhythmia (2, 8.7%) compared to those with a nonstaged, no AtriClip approach (40, 29.4%) (p=0.04) between 3 and 12 months. The staged hybrid approach also had significantly fewer patients requiring cardioversion to restore sinus rhythm during the procedure (p<0.001). Conclusions: A staged hybrid approach with AtriClip placement reduced recurrent arrhythmia between 3 and 12 months compared to a nonstaged hybrid procedure without AtriClip. A benefit was also seen in a steep reduction in the need for cardioversion during the subsequent endocardial ablation to restore sinus rhythm.


Heart Rhythm ◽  
2010 ◽  
Vol 7 (2) ◽  
pp. 173-180 ◽  
Author(s):  
Chin Pang Chan ◽  
Wai Shun Wong ◽  
Satchana Pumprueg ◽  
Srikar Veerareddy ◽  
Sreedhar Billakanty ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document